Ambrx Biopharma Cayman, Inc. Common Stock, Shares Authorized 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Common Stock, Shares Authorized history and growth rate from 2020 to 2023.
  • Ambrx Biopharma Cayman, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2023 was 950 M shares, a 90% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 950 M +450 M +90% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 600 M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 500 M 0 0% Dec 31, 2022 10-Q 2023-08-09
Q2 2022 500 M Jun 30, 2022 6-K 2022-08-29
Q4 2021 500 M +218 M +77% Dec 31, 2021 10-K 2023-03-30
Q4 2020 282 M Dec 31, 2020 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.